Fate Therapeutics Reports First Quarter 2014 Financial Results

Go back to Fate Therapeutics Reports First Quarter 2014 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.32 -0.01 (0.43%)
Previous Close $2.33    52 Week High $4.76 
Open $2.36    52 Week Low $1.46 
Day High $2.39    P/E N/A 
Day Low $2.30    EPS $-1.91 
Volume 339,564